FDA approves Xeomin BLA

FDA approved a BLA from Merz GmbH & Co. KGaA (Frankfurt, Germany) for Xeomin incobotulinumtoxinA to treat cervical dystonia and blepharospasm. The label includes a boxed warning about the risk of botu...